These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36686268)

  • 21. Gene expression profile of Scardovia spp. in the metatranscriptome of root caries.
    Damé-Teixeira N; Parolo CCF; Malz M; Devine DA; DO T
    Braz Oral Res; 2020 May; 34():e042. PubMed ID: 32401932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
    Bedarf JR; Hildebrand F; Coelho LP; Sunagawa S; Bahram M; Goeser F; Bork P; Wüllner U
    Genome Med; 2017 Apr; 9(1):39. PubMed ID: 28449715
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Hanifi GR; Samadi Kafil H; Tayebi Khosroshahi H; Shapouri R; Asgharzadeh M
    Arch Razi Inst; 2021; 76(3):521-528. PubMed ID: 34824745
    [No Abstract]   [Full Text] [Related]  

  • 24. Altered gut microbiota in Parkinson's disease patients with motor complications.
    Takahashi K; Nishiwaki H; Ito M; Iwaoka K; Takahashi K; Suzuki Y; Taguchi K; Yamahara K; Tsuboi Y; Kashihara K; Hirayama M; Ohno K; Maeda T
    Parkinsonism Relat Disord; 2022 Feb; 95():11-17. PubMed ID: 34954497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-Omics Integration in Mice With Parkinson's Disease and the Intervention Effect of Cyanidin-3-
    Wang W; Zhu G; Wang Y; Li W; Yi S; Wang K; Fan L; Tang J; Chen R
    Front Aging Neurosci; 2022; 14():877078. PubMed ID: 35572129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative genomic and phylogenomic analyses of the Bifidobacteriaceae family.
    Lugli GA; Milani C; Turroni F; Duranti S; Mancabelli L; Mangifesta M; Ferrario C; Modesto M; Mattarelli P; Jiří K; van Sinderen D; Ventura M
    BMC Genomics; 2017 Aug; 18(1):568. PubMed ID: 28764658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism.
    Barichella M; Severgnini M; Cilia R; Cassani E; Bolliri C; Caronni S; Ferri V; Cancello R; Ceccarani C; Faierman S; Pinelli G; De Bellis G; Zecca L; Cereda E; Consolandi C; Pezzoli G
    Mov Disord; 2019 Mar; 34(3):396-405. PubMed ID: 30576008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the alteration of gut microbiota and brain function in gender-specific Parkinson's disease based on metagenomic sequencing.
    Zhang M; Zhai Z; Yang B; He L; Wang J; Dai W; Xue L; Yang X; Feng Y; Wang H
    Front Aging Neurosci; 2023; 15():1148546. PubMed ID: 37502423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder.
    Nishiwaki H; Hamaguchi T; Ito M; Ishida T; Maeda T; Kashihara K; Tsuboi Y; Ueyama J; Shimamura T; Mori H; Kurokawa K; Katsuno M; Hirayama M; Ohno K
    mSystems; 2020 Dec; 5(6):. PubMed ID: 33293403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson's disease.
    Shi J; Wang Y; Chen D; Xu X; Li W; Li K; He J; Su W; Luo Q
    Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1917-1929. PubMed ID: 36795141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.
    Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG
    J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Chu C; Yu L; Li Y; Guo H; Zhai Q; Chen W; Tian F
    Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analysis of the characteristics of the intestinal flora in patients with Parkinson's disease complicated with constipation.
    Chen W; Bi Z; Zhu Q; Gao H; Fan Y; Zhang C; Liu X; Ye M
    Am J Transl Res; 2021; 13(12):13710-13722. PubMed ID: 35035709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome.
    Boktor JC; Sharon G; Verhagen Metman LA; Hall DA; Engen PA; Zreloff Z; Hakim DJ; Bostick JW; Ousey J; Lange D; Humphrey G; Ackermann G; Carlin M; Knight R; Keshavarzian A; Mazmanian SK
    Mov Disord; 2023 Mar; 38(3):399-409. PubMed ID: 36691982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can Gut Microbiota Be a Good Predictor for Parkinson's Disease? A Machine Learning Approach.
    Pietrucci D; Teofani A; Unida V; Cerroni R; Biocca S; Stefani A; Desideri A
    Brain Sci; 2020 Apr; 10(4):. PubMed ID: 32325848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galacto-oligosaccharides ameliorate dysbiotic Bifidobacteriaceae decline in Japanese patients with type 2 diabetes.
    Gonai M; Shigehisa A; Kigawa I; Kurasaki K; Chonan O; Matsuki T; Yoshida Y; Aida M; Hamano K; Terauchi Y
    Benef Microbes; 2017 Oct; 8(5):705-716. PubMed ID: 28884590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene encoding the CTP synthetase as an appropriate molecular tool for identification and phylogenetic study of the family Bifidobacteriaceae.
    Killer J; Mekadim C; Pechar R; Bunešová V; Mrázek J; Vlková E
    Microbiologyopen; 2018 Aug; 7(4):e00579. PubMed ID: 29356451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson's disease.
    Yu J; Meng J; Qin Z; Yu Y; Liang Y; Wang Y; Min D
    J Neuroinflammation; 2023 May; 20(1):117. PubMed ID: 37208728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of Nardostachys jatamansi on gut microbiota of rats with Parkinson's disease].
    Wan GH; Wei XJ; Li JY; Yang X; Yu JH; Liu JF; Wang YQ; Lyu Y; Jin ZX; Shi JL
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):499-510. PubMed ID: 35178995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.